Inhibitory effects of ascorbic acid on AP-1 activity and transformation of JB6 cells

International Journal of Oncology

Volumn 8, Issue 2, 1996, Pages 389-393

  Huang, C ^a   Ma, W ^a   Dong, Z ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

AP 1; Ascorbic acid; Transformation; Tumor prevention; Tumor promotion

Indexed keywords

ACTIVATED PROTEIN C; ASCORBIC ACID; EPIDERMAL GROWTH FACTOR; INSULIN; PHORBOL ESTER;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

EID: 0030027812     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.2.389     Document Type: Article

References (12)

1. Bhattacharjee J, Chakraborty AS, Sarkar NK and Basu A: Study of ascorbic acid status in murine and human leukemias. Comp Pathol 95: 87-91, 1985.
2. Ghosh J and Das S: Evaluation of vitamin A and C status in normal and malignant conditions and their possible role in cancer prevention. Jpn J Cancer Res 76: 1174-1178, 1985.
3. Bram S, Frousard P and Guichard M: Vitamin C preferential toxicity of malignant melanoma cells. Nature 284: 629-631, 1980.
4. Harada SI, Masumoto T and Dgata E: Role of ascorbic acid in the regulation of proliferation in osteablast-like MC3T3-E1 cells. J Bone Miner Res 6: 903-907, 1991.
5. Campbell A, Jack T and Cameron E: Reticulum cell sarcoma: two complete spontaneous regressions in response to high dose ascorbic acid therapy. Oncology 48: 495-497, 1991.
6. Henson DE, Block G and Levine M: Ascorbic acid: Biologic functions and relation to cancer. J Natl Cancer Inst 83: 547-550, 1991.
7. Pauling L, Nixon J, Stitt F, Marcusson R, Dunham W, Earth R, Bensch K, Herman Z, Blaisdell B, Tsao C, Prender K, Andrews V, Willoughby R and Zuckerkandi E: Effect of dietary ascorbic acid on the incidence of spontaneous mammary tumors in RIII mice. Proc Natl Acad Sci USA 82: 5185-5189, 1985.
8. Dong ZG, Birrer MJ, Watts RG, Matrisian LM and Colburn NH: Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci USA 91: 609-613, 1994.
9. Dong ZG, Watts RG, Sun Y, Zhan SN and Colburn NH: Progressive elevation of AP-1 activity during preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. IntJOncol 7: 359-364, 1995.
10. Dong ZG, Lavrovsky V and Colburn NH: Transformation reversion induced in JB6 RT10I cells by AP-1 inhibitors. Carcinogenesis 16: 749-756, 1995.
11. Kim SY, Angel P, Lafyatis R, Sporn MB, Karin M and Roberts AB: Autoinduction of transforming growth factor 1 is mediated by the AP-1 complex. Mol Cell Biol 10: 1492-1497, 1990.
12. Pertovaara L, Sistonen L, Bos TJ, Vogt PK, Keski-oja J and Alitalo K: Enhanced jun gene expression is an early genomic response to transforming growth factor stimulation. Mol Cell Biol 9: 1255-1262, 1989.